Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at LD Micro 2017 Invitational
Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company that focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company’s lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which has completed pPhase II clinical trials for the treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients. For more information, visit the company's website at www.intecpharma.com. About NetworkNewsWire NetworkNewsWire (NNW)…







